https://bit.ly/3RPS6wU
Venture capitalists funding rounds turn into main sources of funds for #BioTech startups
Some years ago, the US FDA adopted an "accelerated approval" pathway for therapies for serious diseases where approval depends on surrogate endpoints criteria, such as tumor shrinkage.
This is what we are seeing in the case of #Daraxonrasib and #Pancreatic #Cancer.









